glp-1 drugs key developments 2025 Drugs: Pulse Survey (U.S.) GLP-1s in 2025: Who's Using

Recovery claims No controlled human study establishes the tesamorelin/ipamorelin blend as a treatment for tendon, ligament, muscle, or post-surgical recovery

Our specialist team will conduct a comprehensive metabolic, hormonal, and longevity assessment to determine which GLP-1 therapy or combination of therapies is most appropriate for your individual health profile and goals

It depends entirely on your goal, and we pick from your labs rather than a default

As with any medication, it is essential to weigh the benefits and potential side effects

Is your methylation improving

At the six-month mark, the low-dose group (250 mg/day) demonstrated a 17% increase in whole blood glutathione and a 29% increase in erythrocytes (red blood cells)